• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.13% Nasdaq Down 0.93%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    2.21 0.02(0.90%) Jan 28, 4:00PM EST
    Add to Portfolio
    Prev Close:2.23
    Open:2.25
    Bid:2.19 x 10200
    Ask:2.21 x 8200
    1y Target Est:5.08
    Beta:1.64
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:2.20 - 2.26
    52wk Range:2.00 - 4.22
    Volume:1,075,741
    Avg Vol (3m):1,599,800
    Market Cap:320.75M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICDown 0.90%320.75M
    BMY101.73B
    RHHBYN/A
    SNY120.85B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.59
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback